The Final Design Approval (FDA) represents the second and conclusive phase of the Planning Approval process managed by Eko Atlantic City Management Limited (EACML). It follows the issuance of the Preliminary Design Approval (PDA) and focuses on the Schematic Design Stage, where all architectural, structural, and MEP systems are refined and coordinated in detail. The FDA ensures that the development aligns with approved concept designs, regulatory provisions, and technical standards governing Eko Atlantic City.
To obtain an FDA, the developer must complete and submit a comprehensive package including schematic drawings, peer review reports, soil reports, shoring and environmental studies, and consultants’ certifications. EACML then reviews the submission to verify compliance with the Lot Regulation Sheet, Building Regulations, and all planning requirements. Upon successful assessment, EACML calculates and invoices the applicable planning assessment fees, which must be paid before approval is granted.
Finally, the FDA remains valid for four (4) years, after which re-submission is required if construction has not commenced. This ensures that the project remains consistent with the latest codes, environmental standards, and development policies of Eko Atlantic City. The FDA thus serves as a pivotal regulatory checkpoint, confirming design integrity, safety compliance, and readiness for subsequent building control stages.
Tell us so we know what to improve. It takes one click.
Stay Connected